DOV vs MLTX · P/E 27, rev $4.24B vs $1.41B cap
Dover Corporation (DOV) versus MoonLake Immunotherapeutics (MLTX) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
MoonLake Immunotherapeutics (MLTX) is a biotechnology company listed on US.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
MLTX does not have a complete income-statement cache yet.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. MLTX currently screens at market cap $1.41B.
Not investment advice. Open the DOV and MLTX stock pages for the full models.
Not investment advice.